v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Available-for-sale debt and other securities, amortized cost $ 49,238 $ 39,107
Debt securities, fair value 16,341 11,404
Bank premises and equipment held for sale 18 9
Other short-term investments [1] 17,456 18,876
Total portfolio loans and leases 176,250 122,651
Allowance for loan and lease losses [1] (2,922) (2,253)
Other assets [1] 19,978 12,485
Other liabilities [1] 6,642 4,235
Long-term debt [1] $ 18,753 $ 13,589
Common stock, par value (in dollars per share) $ 2.22 $ 2.22
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, shares issued, not disclosed true true
Common stock, outstanding (in shares) 905,822,556 661,197,787
Treasury stock, common (in shares) 258,416,111 262,694,794
Preferred stock, authorized (in shares) 500,000 500,000
Preferred stock, unissued (in shares) 36,000 436,000
Preferred stock, liquidation preference per share (in dollars per share) $ 25,000 $ 25,000
Residential Mortgage    
Loans held for sale $ 714 $ 658
Loans measured at FV 105 106
Allowance for loan and lease losses $ (108) $ (109)
Preferred Class B    
Preferred stock, authorized (in shares) 500,000 500,000
Preferred stock, unissued (in shares) 300,000 300,000
Preferred stock, liquidation preference per share (in dollars per share) $ 1,000 $ 1,000
Variable Interest Entity, Primary Beneficiary | Automobile And Solar Loan    
Other short-term investments $ 38 $ 38
Total portfolio loans and leases 463 554
Allowance for loan and lease losses (8) (9)
Other assets 3 3
Other liabilities 10 11
Long-term debt $ 391 $ 473
[1] Includes $38 and $38 of other short-term investments, $463 and $554 of portfolio loans and leases, $(8) and $(9) of ALLL, $3 and $3 of other assets, $10 and $11 of other liabilities and $391 and $473 of long-term debt from consolidated VIEs that are included in their respective captions above at March 31, 2026 and December 31, 2025, respectively. For further information, refer to Note 10.